Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H24N2O2.ClH |
| Molecular Weight | 360.878 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=C2N=CC=C(C(=O)CC[C@@H]3CCNC[C@@H]3C=C)C2=C1
InChI
InChIKey=YUBRJAHSRSIPKX-LDXVYITESA-N
InChI=1S/C20H24N2O2.ClH/c1-3-14-13-21-10-8-15(14)4-7-20(23)17-9-11-22-19-6-5-16(24-2)12-18(17)19;/h3,5-6,9,11-12,14-15,21H,1,4,7-8,10,13H2,2H3;1H/t14-,15+;/m0./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C20H24N2O2 |
| Molecular Weight | 324.4168 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Viquidil is an isomer of quinidine and papaverine derivative. Viquidil is used for treatment of disturbances of cerebral blood flow and metabolism. Viquidil, however, appeared to be approximately twice as potent as papaverine in inhibition of thrombus formation in the microvasculature and was apparently without toxic side-effects.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:26:20 GMT 2023
by
admin
on
Sat Dec 16 01:26:20 GMT 2023
|
| Record UNII |
U6FXT2V136
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
236343
Created by
admin on Sat Dec 16 01:26:20 GMT 2023 , Edited by admin on Sat Dec 16 01:26:20 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID30966589
Created by
admin on Sat Dec 16 01:26:20 GMT 2023 , Edited by admin on Sat Dec 16 01:26:20 GMT 2023
|
PRIMARY | |||
|
198279
Created by
admin on Sat Dec 16 01:26:20 GMT 2023 , Edited by admin on Sat Dec 16 01:26:20 GMT 2023
|
PRIMARY | |||
|
52211-63-9
Created by
admin on Sat Dec 16 01:26:20 GMT 2023 , Edited by admin on Sat Dec 16 01:26:20 GMT 2023
|
PRIMARY | |||
|
100000087884
Created by
admin on Sat Dec 16 01:26:20 GMT 2023 , Edited by admin on Sat Dec 16 01:26:20 GMT 2023
|
PRIMARY | |||
|
SUB05109MIG
Created by
admin on Sat Dec 16 01:26:20 GMT 2023 , Edited by admin on Sat Dec 16 01:26:20 GMT 2023
|
PRIMARY | |||
|
U6FXT2V136
Created by
admin on Sat Dec 16 01:26:20 GMT 2023 , Edited by admin on Sat Dec 16 01:26:20 GMT 2023
|
PRIMARY | |||
|
m11469
Created by
admin on Sat Dec 16 01:26:20 GMT 2023 , Edited by admin on Sat Dec 16 01:26:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
257-739-9
Created by
admin on Sat Dec 16 01:26:20 GMT 2023 , Edited by admin on Sat Dec 16 01:26:20 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |